ASCO: As FDA’s Zolbetuximab Decision Looms, Astellas Looks To Meet Testing Challenge

Astellas stand at ASCO 2024
• Source: Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from ASCO

More from Conferences